ARUP, ASI in Pathology Collaboration
News Nov 23, 2016
Applied Spectral Imaging (ASI) announced that they have entered a collaboration with ARUP Laboratories to facilitate the development and commercialization of advanced digital pathology solutions enhancing workflow efficiencies and simplifying the management and accessibility of clinical data.
This collaboration will bring to pathology, cytogenetics, and research labs, novel image quality and robust analysis algorithms that resolve the bottleneck of image analysis. The developed imaging platform will also transform the way pathologists deliver professional services from remote locations.
“ASI is proud to partner with ARUP Laboratories, a national reference laboratory and a worldwide leader in innovative laboratory research and development. With the professional consultancy and expertise of ARUP, throughout the development of our next-version imaging platform, we will be offering our wide customer base, an imaging solution that best supports their FISH and brightfield workflows,” said Limor Shiposh, chief executive officer of ASI. “This collaboration aligns the shared mission of both organizations: to improve the lives of patients worldwide by optimizing the scanning process to save valuable time and providing superior image quality, accurate image analysis, and enhanced access to data management and reporting tools,” Mrs. Shiposh added.
“The collaboration with ASI will provide state of the art pathology practice at ARUP and its delivery to ARUP’s clients,” said Dr. Mohamed Salama, chief of Hematopathology at ARUP Laboratories and professor of pathology at the University of Utah. “ARUP’s increasing pathology sample volumes require advanced workflow efficiencies, as well as creative data management and accessibility solutions. These collaboratively developed novel tools will enable improved efficiency and enhance accuracy. ARUP is one of the pioneers in early digital pathology adoption and is always seeking to leverage the use of technology with commitment to improved patient care.”
Story from Applied Spectral Imaging. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest DiagnosticsNews
Partnership will include broad range of value-based programs, rewarding high-quality, easily accessible laboratory services at the best value and real-time data sharing to drive more personalized care support.READ MORE
Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer DrugsNews
Under the agreement, Shuwen will develop companion diagnostics for Bliss’ oncology drug candidates. Shuwen also commits to provide testing services in its CAP-certified central labs for BlissBio’ clinical trials. The terms of the collaboration are undisclosed.READ MORE
Comments | 0 ADD COMMENT
International Conference on Central Nervous System and Therapeutics
Nov 12 - Nov 14, 2018